Clinical Trial Update: Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia [Phase 2, Phase 3]

View source ↗

Summary

The phase 2/3 pilot trial of varenicline (Chantix) for Friedreich's Ataxia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• CHANTIX (varenicline tartrate)

Snippet

Sponsor: University of South Florida | Conditions: Friedreich's Ataxia | Phase 2, Phase 3 | Status: TERMINATED